Virtue Diagnostics closes $100 million Series B Funding
SHANGHAI, Jan. 6, 2022 /PRNewswire/ — Virtue Diagnostics, an innovative IVD company, has just announced closing US$100 million in Series B funding. Virtue Diagnostics, founded in 2019, is focused on clinical tests for China and emerging markets. Sequoia China and Morningside Ventures jointly led the investment round with ORIZA Holdings. Existing investors Lilly Asia Ventures […]